Considering the increased diagnostic value by combination of HE4 with other biomarkers, particularly CA19-9 and CA15-3, and the higher protein level in early stage of cancer, HE4 appears to be a promising marker for pancreatic adenocarcinomas. This evidence concerns the gene WFDC2 and cancer.